To elucidate the possible contribution of PP2A to the KCa1.1 inhibition-induced down-regulation of CYP3A4 in cancer spheroid models, we examined the effects of the PP2A activator, FTY720-P, on the expression level of CYP3A4 transcripts. The gene discussed is CYP3A4; the disease is cancer.